Royalty Pharma plc (NASDAQ:RPRX) Q4 2024 Earnings Call Transcript February 11, 2025
Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.3509 EPS, expectations were $0.99.
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Royalty Pharma Fourth Quarter Earnings Conference. I would like now to turn the conference over to George Grofik, Senior Vice President and Head of Investor Relations and Communication. Please go ahead, sir.
George Grofik: Good...
